Background. Encephalitis is associated with significant mortality and morbidity, but its cause remains largely unknown. We designed a national prospective study in France in 2007 to describe patients with encephalitis, investigate the etiologic diagnosis of encephalitis, and assess risk factors associated with death.
vous system (CNS) infection after a benign infection are unknown, but recent data are consistent with genetic risk factors [4] . Infectious encephalitis is mainly caused by viruses, with herpes simplex virus (HSV) being the most frequently isolated [5] [6] [7] . However, recent studies have emphasized the role of bacteria, especially Mycoplasma pneumoniae [8] , fungi [9] , and parasites [10] .
Formerly rare or unknown pathogens causing encephalitis have recently emerged or reemerged, mainly in outbreak locations: West Nile virus [11] , Nipah virus [12] , and enterovirus 71 [13] . Some of these pathogens result in high case-fatality rates or severe sequelae, which makes encephalitis an important public health issue.
The etiologic origin of encephalitis remains undetermined in most patients despite a wide range of diagnostic tools (molecular analysis, serologic testing, direct examination) [6, [14] [15] [16] [17] [18] [19] . In France, it is not mandatory to notify the public health authorities about infectious encephalitis. In the Programme de Médicalisation du Système d'Information (French National Hospital Discharge Database), no cause of encephalitis was reported for 80% of patients [19] . HSV was the most frequently reported cause of encephalitis (9% of all cases recorded during the 3 years), followed by varicella-zoster virus (VZV) (5%).
We designed a prospective study in mainland France to describe patients with encephalitis occurring in 2007, to investigate the etiologic diagnosis of the encephalitis through a standardized procedure, and to assess the risk factors associated with death during hospitalization. This study was also an opportunity to evaluate the usefulness of the recommendations of the Société de Pathologie Infectieuse de Langue Française (SPILF) (French Society of Infectious Diseases) for the treatment of patients with encephalitis.
METHODS
Patients with encephalitis were enrolled in a national multicenter study in voluntary infectious diseases units, neurologic units, pediatric units, and intensive care units (ICUs). A patient with encephalitis was defined as a patient aged у28 days who was hospitalized in mainland France in 2007 with (1) an acute onset of illness, (2) at least 1 abnormality of the cerebrospinal fluid (white blood cell count of у4 cells/mm 3 or protein level of у40 mg/dL), (3) temperature of у38ЊC, and (4) decreased consciousness or seizures or altered mental status or focal neurologic signs.
To avoid including patients with aseptic meningitis without brain involvement, the study design encompassed the exclusion of surviving patients with a hospital stay of fewer than 5 days. Additional exclusion criteria were positive human immunodeficiency virus status, meningitis without clinical brain involvement, brain abscess, prion diseases, cerebral malaria, and noninfectious CNS diseases Etiologic investigation was performed according to the recommendations of SPILF for the treatment of patients with encephalitis. The diagnostic procedure recommended by SPILF is divided into 3 successive steps according to the frequency of infectious agents as a cause of encephalitis and the need to start an early treatment for some pathogens (Table 1) . It also encompasses guidance about the most effective diagnostic test and the most accurate sample to be tested for each pathogen in the context of neurologic signs, according to the international literature (Table 1) . For nonroutine tests, the recommendations mention the national reference laboratory. This procedure was diffused to all hospitals participating in the study and is published on the SPILF Web site [20] .
Medical history, comorbidities, and ongoing treatments at the time of onset and clinical, biological, imaging, and demographic data were collected using standardized questionnaires. Clinical data were recorded on admission, 5 days after admission, and on discharge. Neuroimaging results are not described in this article because of the diversity of machines and images readers.
All medical files were reviewed by a single multidisciplinary, national panel of senior experts from the Steering Committee, including an infectious diseases specialist, an ICU specialist, a neurologist, a pediatrician, 2 virologists, a bacteriologist, and an epidemiologist. The panel validated the diagnosis and classified patients as having confirmed, probable, or possible cases of encephalitis according to clinical data, imaging findings, and biological test results. A confirmed case was defined as direct identification of an infectious agent in the CSF. A probable case was defined as direct identification of an infectious agent in any biological sample except CSF, a seroconversion in paired serum samples, or a high immunoglobulin (Ig) M titer in the CSF. A possible case was defined as a high IgM titer in a single serum sample or the combination of epidemiologic and clinical features, imaging findings, and biochemical analysis results strongly evocative of a disease and a negative result on a poorly sensitive test (eg, CSF culture for Mycobacterium tuberculosis). Patients presenting with nonspecific clinical signs, imaging, and chemistry results and positive serologic test results obtained by tests with low specificity or with low titers were considered to have false-positive results and classified as having "no causative infectious agent identified."
Data were analyzed using Stata statistical software, version 9 (Stata Corp). A 2-tailed P value !.05 was considered statistically significant. For those patients whose vital status at discharge was known, the association between demographic and clinical variables and death during hospitalization was assessed by the odds ratio (OR) and its associated Wald confidence intervals (CIs). All variables individually associated with death at a significance level of were included in a multivar-P р .25 iable logistic regression model. Variable selection was performed according to a backward-stepwise procedure. The causative agent was retained in the model irrespective of the significance of its association with the outcome of interest. To avoid loss of information, quantitative variables were treated as continuous variables, and the linearity assumption was checked in univariate analysis and in the final model. Goodness of fit of the final model was assessed by the Hosmer-Lemeshow test.
Informed written consent was obtained from all patients or from their parents for children aged !18 years. According to French regulations, consent could be obtained from the relative responsible for legal matters or from the attending physician for patients unable to give consent because of their severe condition. However, this consent had to be confirmed by patients once they were able. Patients were free to withdraw their con- [6, 18] . CMV, cytomegalovirus; CSF, cerebrospinal fluid; EBV, Epstein-Barr virus; ELISA, enzyme-linked immunosorbent assay; HHV, human herpesvirus; HIV, human immunodeficiency virus; HSV, herpes simplex virus; LCMV, lymphocytic choriomeningitis virus; PCR, polymerase chain reaction; TBE, tick-borne encephalitis; VZV, varicella-zoster virus; WB, Western blot. a A pertinent history or pertinent epidemiologic features could change the order of the steps. b Multiplex PCR investigating all herpesviruses could be used. For HSV and VZV, if the lumbar puncture had been performed in the first 4 days after onset of neurologic signs and if the PCR result was negative, an additional lumbar puncture had to be performed on a CSF sample obtained after day 4. (Table 2 ). Data from the 253 patients with acute infectious encephalitis and no exclusion criteria were analyzed. Thirteen patients (5%) had their main place of residence outside France, and 240 patients lived in 60 districts throughout France (Figure 1 ). Sixty-one percent were male. The age of the patients ranged from 1 month to 89 years (median age, 55 years; mean age, 50 years). Twenty-six patients (10%) were children aged !16 years.
Etiology. The etiologic investigation yielded an infectious cause of the encephalitis in 131 patients (52%). No coinfection was detected. One hundred one patients (77%) had confirmed cases of encephalitis, 18 (14%) had probable cases, and 12 (9%) had possible cases. Among these 131 patients, 90 (69%) had viral encephalitis, 40 (30%) had bacterial encephalitis, and 1 patient had fungal encephalitis. The most frequent etiologic agents were HSV (42%), VZV (15%), M. tuberculosis (15%), and Listeria monocytogenes (10%). All infectious agents identified are summarized in Table 3 . Another 19 patients with a positive serologic test result were considered to have no determined cause of their disease because of the lack of specificity of the result (IgG without IgM, IgM under the laboratory threshold, or positive serologic test results for several infectious agents in the same patient).
Clinical patterns. Among the 253 patients enrolled, 77 (30%) reported comorbidities, mainly congestive cardiac failure (15 patients [6%]) and cancer (14 patients [5.5%]). Seventeen patients (7%) reported being treated for a mental illness or a psychiatric disorder at the time of onset of encephalitis; their mean delay between onset of neurologic signs and hospitalization was not different from other patients ( ). P p .79 On admission, 240 patients (95%) presented with an altered mental status, 94 (37%) with focal neurologic signs, 76 (30%) with seizures, 64 (25%) with decreased consciousness, and 13 (5%) with coma. On day 5 after admission, 165 (65%) had an altered mental status, 80 (32%) had focal neurologic signs, 50 (21%) had decreased consciousness, 18 (7%) had seizures, and 18 (7%) were in comas. One hundred eighteen patients (47%) were admitted to an ICU. Mechanical ventilation was required in 73 patients (29%) for a median duration of 7 days. The main clinical features of the 253 patients according to the cause are described in Table 4 . Their median hospital stay was 20 days (range, 2-284 days).
A fatal outcome occurred in 26 patients (10%) during hospitalization. All were adults aged 22 to 86 years (median age, 62.5 years), and 62% were male. Their median length of the hospital stay was 23 days (range, 2-155 days). The infectious cause of the encephalitis was known for 20 (77%): M. tuberculosis ( ), L. monocytogenes ( ), HSV ( ), VZV ( n p 6 n p 6 n p 3 n p ), cytomegalovirus ( ), and West Nile virus ( ). 3 n p 1 n p 1 Four foreign patients transferred to a hospital abroad were lost to follow-up with an unknown outcome. Among 223 surviving patients, 137 (61%) were discharged to home, 63 (28%) to a convalescence facility, and 8 (3.5%) to a long-term facility. Nine patients (4%) were transferred to their country of origin during hospitalization, and 6 (3%) who lived on their own before encephalitis moved into a parent's home or a nursing home after hospitalization. On discharge, 140 patients (62%) still had neurologic signs, and 22 (10%) had behavioral disorders.
All variables initially included in the logistic regression are listed in Table 5 . Factors independently associated with death during hospitalization identified by the multivariable analysis were age, cancer, immunosuppressive treatment before onset, percentage of hospitalized patients receiving mechanical ventilation, cause of encephalitis, coma at day 5 after admission, and sepsis at day 5 ( Table 5 ). The Hosmer-Lemeshow x 2 test result was 3.19 ( ), suggesting a good fit of the model. P p .96
DISCUSSION
Our study resulted in a real improvement in the proportion of patients with an etiologic diagnosis of encephalitis (52%) when [19] ) and other similar studies (37% in the study by Glaser et al [6] ). This objective was achieved because of extensive testing of patients.
The most frequent causes of encephalitis in our patients were HSV and VZV, confirming previous results [14, 15, 18, 19] , but they appear to be more frequent in our sample. In other publications, VZV was the agent most frequently identified before HSV, especially in children [16, 17, 21] . On the contrary, a recent article less frequently identified VZV [6] .
We found a higher proportion of encephalitis due to tuberculosis (8%) and listeriosis (5%) than in other studies (1% for M. tuberculosis and no listeriosis in the study by Glaser et al [6] and no M. tuberculosis or listeriosis in the study by Koskiniemi et al [16] ). We are confident that our tuberculosis patients had encephalitis rather than meningitis because the case definition included clinical patterns specifically encountered in encephalitis, such as focal neurologic signs. After a 30-year decrease, the incidence of tuberculosis in France is now among the lowest in Europe [22] . We identified neurotuberculosis in patients who most likely had ancient infections but recent clinical resurgence. Therefore, they are representative of tuberculosis incidence in the past. Listeriosis incidence in France was always higher than many European countries. However, an unexplained increased was reported in Europe since 2006 [23] . Our results may reflect both the high incidence in France and the recently identified trend of listeriosis.
A lower proportion of encephalitis due to M. pneumoniae or enterovirus was observed in our study than in other studies [6, 16, 24] . These infectious agents are described as causes of pediatric encephalitis. The fact that we enrolled few children in our study (10%) could explain this low prevalence. We chose a stringent case definition, which possibly resulted in the exclusion of benign cases. Moreover, because of our strict microbiological criteria for the etiologic diagnosis, 3 patients with low IgM Mycoplasma titers in serum were classified as having encephalitis with no cause identified, and no patient had a confirmed diagnosis of M. pneumoniae (the 2 patients with a Mycoplasma diagnosis had probable cases).
Arboviruses were rarely identified in our study population (eg, tick-borne encephalitis virus or Toscana virus). These find- ings are consistent with available data in France indicating that arboviruses' circulation is rare and limited to specific areas, such as tick-borne encephalitis at the German and Swiss borders [25] and Toscana virus along the Mediterranean coast [26] . The only case of West Nile virus infection identified in our study was imported from Egypt. Toscana virus is known to be a cause of meningitis rather than encephalitis, but rare encephalitis cases have been previously described [26] . We were able to identify rare bacterial causes of encephalitis, such as Francisella tularensis or Legionella pneumophila, with strong evidence for the diagnostic. The role of these bacteria in CNS infections is anecdotic [27, 28] , but our findings suggest that a certain number of infectious encephalitis cases could be caused by bacterial pathogens unusually associated with CNS infections.
No coinfections were identified in our study. This might be due to the tiered testing approach: once an agent was identified, no additional testing was performed.
A nonnegligible proportion of patients (7%) reported being treated for psychiatric disorders at the onset of encephalitis. These conditions were reported by patients on admission; it is therefore possible that the prevalence was overestimated. Moreover, the consumption of psychiatric drugs in the French population is among the highest worldwide. In a Swedish study, 2.5% of 236 patients with HSV encephalitis were reported as having a psychiatric disorder before the encephalitis [29] . The consumption of psychotropic drugs might have delayed the diagnosis of encephalitis by leading to an incorrect interpretation of early neurologic signs. However, in our study, the duration between the onset of neurologic signs and hospitali- zation was not different in patients with psychotropic treatment, suggesting that their treatment had no influence on the diagnosis of encephalitis. Nearly one-half of the patients reported early signs before neurologic onset. Because of the nonspecific nature of such signs and the varying duration before neurologic signs, their value as early clinical features of encephalitis is questionable. The clinical and biological signs recorded on admission and on day 5 allowed us to describe the main pattern of encephalitis due to HSV, VZV, tuberculosis, and listeriosis in our patients. In our patients, the median protein level was higher in bacterial infections than viral infections. However, the range of white blood cell counts in patients with VZV was comparable to that of patients with listeriosis and wider than that of patients with tuberculosis. Our results suggest that no single clinical or CSF feature is sufficient to evoke the etiologic cause of the encephalitis. Consequently, the complete clinical picture should be considered when giving early empirical treatment while awaiting microbiological confirmation.
The highest case-fatality rates were found in patients with listeriosis (46%) and patients with tuberculosis (30%). For patients with HSV encephalitis, it was lower than previously published [29, 30] . HSV encephalitis with nonsevere presentation has been previously described [31] . The diversity of recruiting units and hospitals might be responsible for the enrollment of patients with less severe HSV in our study. Our recruitment is possibly more representative of the clinical diversity of HSV encephalitis in the French population.
As expected, a fatal outcome was associated with variables indicating clinical severity (sepsis at day 5, coma at day 5, and percentage of hospitalized patients receiving mechanical ventilation). However, none of the variables describing the clinical picture on admission were associated with death in the final model, suggesting that the initial clinical patterns are of little additional value in predicting the outcome compared with those present at day 5 after hospitalization. Besides, cancer and immunosuppressive treatment were associated with death after adjustment for clinical severity. Bacterial causes of encephalitis and VZV infections were associated with death. The causative agent and the comorbidities could be useful as prognostic factors, although the causative agent might not be known early, especially for fastidious germs such as M. tuberculosis. The OR of some variables independently associated with death had wide CIs, which could be attributed to the low number of dead patients. This low number resulted in a lower statistical power and a consequent loss of precision in the estimations. The risk factors for death were studied to predict a poor outcome during the hospitalization for the acute episode. Death may have occurred after the discharge for some patients with different associated risk factors. Moreover, some patients were discharged with ongoing symptoms, some of which could result in temporary or permanent impairment. Performing the etiologic investigation at the local level maximized the immediate individual benefit for the patients by rapidly identifying the causative agent, giving a prognosis and proposing a specific treatment if possible.
The strengths of our study were its prospective design and multidisciplinary recruitment. We are confident in the interpretation of the study results because of the systematic review of all patients' medical files by a panel of experts representing all medical specialties potentially involved in encephalitis management. The patients were enrolled by primary secondary and tertiary care hospitals and therefore are likely to be representative of the range of clinical presentations and causes encountered in France. A limitation of the study was the small number of children enrolled, which could suggest underreporting of cases with possible consequences on the causes identified. However, no data suggest that our adult patients were not representative of the population of patients with encephalitis in mainland France.
In conclusion, our study identified HSV and VZV as major causes of encephalitis in France and demonstrated that tuberculosis and listeriosis account for high case-fatality rates for this syndrome, although their role has rarely been considered important in encephalitis. This study provided the opportunity to set up a biobank with biological samples obtained from patients. This collection will be used for further fundamental research projects. The long-term outcome and sequelae of the patients will be described 2 years after discharge with regard to the causative agent and the clinical features present during the acute episode.
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